Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Allogeneic heamatopoietic stem cell transplant in patients with refractory T-cell large granular lymphocytic leukaemia: A single-centre experience.
Journal: British journal of haematology
Published: June 03, 2026
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin.
Journal: Blood cancer journal
Published: February 02, 2026
Efficacy of Splenectomy for Hematologic Malignancies: A Retrospective Cohort Study.
Journal: Annals of surgery
Published: January 28, 2026
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies.
Journal: Hematology/oncology clinics of North America
Published: January 03, 2026
Polatuzumab Vedotin Combined With R-ICE (PolaR-ICE) as Second-Line Therapy in Diffuse Large B-Cell Lymphoma.
Journal: American journal of hematology
Published: October 03, 2025
Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantation.
Journal: Diabetes, obesity & metabolism
Published: September 26, 2025
Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis.
Journal: Cytometry. Part B, Clinical cytometry
Published: August 06, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 26, 2025
Last Updated: 09/26/2026